MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Role of dopamine and GABA during subthalamic and pallidal deep brain stimulation: Evidence of dopamine release during subthalamic Deep Brain Stimulation

A. Nakajima, Y. Shimo, T. Uka, N. Hattori (Tokyo, Japan)

Meeting: 2016 International Congress

Abstract Number: 809

Keywords: Basal ganglia, Deep brain stimulation (DBS), Dopamine, Striatum

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Pathophysiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: We recorded the single-unit activity of striatal cholinergic interneurons of healthy monkeys during high-frequency stimulation (HFS) of the subthalamic nucleus (STN) and globus pallidus (GPi) and also measured dopamine release during stimulation of these targets to examine the therapeutic mechanisms of deep brain stimulation (DBS) using electrophysiological, pharmacological, and electrochemical methods.

Background: DBS of STN and GPi is an established surgical therapy for patients with Parkinson’s disease (PD). Inconsistent DBS efficacy may result from limited understanding of the therapeutic mechanisms such as the contribution of striatal cholinergic interneurons.

Methods: Neuronal activity of tonically active neurons (TANs) in the putamen was extracellularly recorded during STN- and GPi-HFS (130 Hz; 60 µs; 0.4 mA and 0.1 mA for 30 s and 10 s, respectively) in three healthy monkeys. To examine the neurotransmitter pathways that are involved in regulating TAN activity, we locally injected several receptor modulators and assessed their influence on the activity. Furthermore, we measured real-time dopamine release using fast-scan cyclic voltammetry during STN-HFS.

Results: We measured the spiking activities of 96 TANs during STN-HFS and 25 during GPi-HFS. Both STN- and GPi-HFS reduced the interneuron spike rate (86% of recorded neurons during STN-HFS and 79% during GPi-HFS, p < 0.05, Mann–Whitney U test). Striatal infusion of a D2 receptor antagonist blocked the reduction in the spike rate that was induced by STN-HFS but not by GPi-HFS. STN-HFS, not GPi-HFS, induced phasic dopamine release in the striatum, as revealed by in vivo voltammetry.

Conclusions: These results indicate reduced striatal cholinergic tone in response to DBS and suggest distinct therapeutic mechanisms for STN- and GPi-DBS. Furthermore, STN-DBS efficacy may depend on a preserved striatal dopaminergic signaling, suggesting that STN-DBS should be considered for early stage PD.

This work is partially presented at 5th Asian and Oceanian Parkinson’s disease and Movement disorders Congress 2015.

To cite this abstract in AMA style:

A. Nakajima, Y. Shimo, T. Uka, N. Hattori. Role of dopamine and GABA during subthalamic and pallidal deep brain stimulation: Evidence of dopamine release during subthalamic Deep Brain Stimulation [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/role-of-dopamine-and-gaba-during-subthalamic-and-pallidal-deep-brain-stimulation-evidence-of-dopamine-release-during-subthalamic-deep-brain-stimulation/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/role-of-dopamine-and-gaba-during-subthalamic-and-pallidal-deep-brain-stimulation-evidence-of-dopamine-release-during-subthalamic-deep-brain-stimulation/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley